Mustgrow Biologics Corp
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home … Read more
Mustgrow Biologics Corp (MGROF) - Total Assets
Latest total assets as of September 2025: $6.06 Million USD
Based on the latest financial reports, Mustgrow Biologics Corp (MGROF) holds total assets worth $6.06 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mustgrow Biologics Corp - Total Assets Trend (2016–2024)
This chart illustrates how Mustgrow Biologics Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Mustgrow Biologics Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Mustgrow Biologics Corp's total assets of $6.06 Million consist of 86.0% current assets and 14.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 55.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $1.43 Million | 26.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Mustgrow Biologics Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mustgrow Biologics Corp's current assets represent 86.0% of total assets in 2024, a decrease from 100.0% in 2016.
- Cash Position: Cash and equivalents constituted 55.3% of total assets in 2024, down from 100.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 26.4% of total assets.
Mustgrow Biologics Corp Competitors by Total Assets
Key competitors of Mustgrow Biologics Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nanjing Red Sun Co Ltd
SHE:000525
|
China | CN¥6.84 Billion |
|
ADAMA Ltd
SHE:000553
|
China | CN¥49.93 Billion |
|
Grand Industrial Holding Co Ltd
SHE:000626
|
China | CN¥8.43 Billion |
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥50.97 Billion |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥5.17 Billion |
|
Asia Potash International Investment Guangzhou Co Ltd
SHE:000893
|
China | CN¥19.38 Billion |
|
Hubei Xinyangfeng Fertilizer Co Ltd
SHE:000902
|
China | CN¥19.75 Billion |
|
Sichuan Lutianhua Co Ltd
SHE:000912
|
China | CN¥9.46 Billion |
Mustgrow Biologics Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Mustgrow Biologics Corp generates 0.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Mustgrow Biologics Corp is currently not profitable relative to its asset base.
Mustgrow Biologics Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.89 | 5.38 | 9.62 |
| Quick Ratio | 1.25 | 4.87 | 9.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.67 Million | $ 3.51 Million | $ 3.02 Million |
Mustgrow Biologics Corp - Advanced Valuation Insights
This section examines the relationship between Mustgrow Biologics Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.03 |
| Latest Market Cap to Assets Ratio | 4.40 |
| Asset Growth Rate (YoY) | -21.9% |
| Total Assets | $5.42 Million |
| Market Capitalization | $23.82 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Mustgrow Biologics Corp's assets at a significant premium ( 4.40x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Mustgrow Biologics Corp's assets decreased by 21.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Mustgrow Biologics Corp (2016–2024)
The table below shows the annual total assets of Mustgrow Biologics Corp from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $5.42 Million | -21.93% |
| 2023-12-31 | $6.94 Million | -2.75% |
| 2022-12-31 | $7.13 Million | -26.46% |
| 2021-12-31 | $9.70 Million | +187.72% |
| 2020-12-31 | $3.37 Million | -17.61% |
| 2019-12-31 | $4.09 Million | +666.02% |
| 2018-12-31 | $534.28K | +177.82% |
| 2017-12-31 | $192.31K | +20424.33% |
| 2016-12-31 | $937.00 | -- |